Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$76.66
0.440.58%
At close: -
$77.35
0.690.90%
After Hours: 7:44 PM EDT
Comments
Loading...
Edwards Lifesciences Analyst Ratings and Price Targets | NYSE:EW | Benzinga
Edwards Lifesciences Corp has a consensus price target of $81.09 based on the ratings of 23 analysts. The high is $105 issued by Mizuho on April 11, 2024. The low is $60 issued by Wolfe Research on January 16, 2025. The 3 most-recent analyst ratings were released by Citigroup, Piper Sandler, and Canaccord Genuity on May 22, 2025, May 13, 2025, and April 25, 2025, respectively. With an average price target of $84.33 between Citigroup, Piper Sandler, and Canaccord Genuity, there's an implied 9.03% upside for Edwards Lifesciences Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Piper Sandler
Canaccord Genuity
Baird
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Edwards Lifesciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/22/2025 | Buy Now | 22.82% | Citigroup | Joanne Wuensch74% | $84 → $95 | Maintains | Buy | Get Alert |
| 05/13/2025 | Buy Now | 7.3% | Piper Sandler | Adam Maeder63% | $80 → $83 | Maintains | Overweight | Get Alert |
| 04/25/2025 | Buy Now | -3.04% | Canaccord Genuity | William Plovanic55% | $71 → $75 | Maintains | Hold | Get Alert |
| 04/24/2025 | Buy Now | 3.43% | Piper Sandler | Adam Maeder63% | $73 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 04/24/2025 | Buy Now | -3.04% | Baird | David Rescott65% | $72 → $75 | Maintains | Neutral | Get Alert |
| 04/11/2025 | Buy Now | -3.04% | Truist Securities | Richard Newitter74% | $78 → $75 | Maintains | Hold | Get Alert |
| 02/13/2025 | Buy Now | 16.35% | Barclays | Matt Miksic67% | $88 → $90 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | -8.21% | Canaccord Genuity | William Plovanic55% | $68 → $71 | Maintains | Hold | Get Alert |
| 02/12/2025 | Buy Now | 9.89% | RBC Capital | Shagun Singh57% | $85 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 02/12/2025 | Buy Now | -5.62% | Piper Sandler | Adam Maeder63% | $70 → $73 | Maintains | Neutral | Get Alert |
| 02/12/2025 | Buy Now | -5.62% | Evercore ISI Group | Vijay Kumar51% | $75 → $73 | Maintains | In-Line | Get Alert |
| 02/12/2025 | Buy Now | -3.04% | Morgan Stanley | Patrick Wood43% | $70 → $75 | Maintains | Equal-Weight | Get Alert |
| 01/30/2025 | Buy Now | 16.35% | Stifel | Rick Wise74% | $75 → $90 | Upgrade | Hold → Buy | Get Alert |
| 01/16/2025 | Buy Now | -22.43% | Wolfe Research | Mike Polark66% | $60 → $60 | Downgrade | Peer Perform → Underperform | Get Alert |
| 12/16/2024 | Buy Now | 16.35% | B of A Securities | Travis Steed58% | $82 → $90 | Upgrade | Neutral → Buy | Get Alert |
| 12/11/2024 | Buy Now | 7.3% | Citigroup | Joanne Wuensch74% | $81 → $83 | Maintains | Buy | Get Alert |
| 12/05/2024 | Buy Now | 16.35% | Goldman Sachs | David Roman40% | $81 → $90 | Maintains | Buy | Get Alert |
| 12/05/2024 | Buy Now | 0.84% | Truist Securities | Richard Newitter74% | $70 → $78 | Reiterates | Hold → Hold | Get Alert |
| 12/05/2024 | Buy Now | -3.04% | Stifel | Rick Wise74% | $70 → $75 | Maintains | Hold | Get Alert |
| 12/05/2024 | Buy Now | 9.89% | RBC Capital | Shagun Singh57% | $80 → $85 | Maintains | Outperform | Get Alert |
| 12/05/2024 | Buy Now | -12.09% | Canaccord Genuity | William Plovanic55% | $63 → $68 | Maintains | Hold | Get Alert |
| 12/02/2024 | Buy Now | 13.77% | Barclays | Matt Miksic67% | $85 → $88 | Maintains | Overweight | Get Alert |
| 11/27/2024 | Buy Now | 3.43% | RBC Capital | Shagun Singh57% | $75 → $80 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | -18.55% | Canaccord Genuity | William Plovanic55% | $66 → $63 | Maintains | Hold | Get Alert |
| 10/25/2024 | Buy Now | 0.84% | JP Morgan | Robbie Marcus67% | $72 → $78 | Maintains | Neutral | Get Alert |
| 10/25/2024 | Buy Now | -9.5% | Piper Sandler | Adam Maeder63% | $73 → $70 | Maintains | Neutral | Get Alert |
| 10/25/2024 | Buy Now | -9.5% | Truist Securities | Richard Newitter74% | $71 → $70 | Maintains | Hold | Get Alert |
| 10/25/2024 | Buy Now | -12.09% | Baird | David Rescott65% | $73 → $68 | Maintains | Neutral | Get Alert |
| 10/11/2024 | Buy Now | -9.5% | Morgan Stanley | Patrick Wood43% | → $70 | Reinstates | → Equal-Weight | Get Alert |
| 10/08/2024 | Buy Now | -3.04% | RBC Capital | Shagun Singh57% | $85 → $75 | Maintains | Outperform | Get Alert |
| 10/07/2024 | Buy Now | -14.67% | Canaccord Genuity | William Plovanic55% | $77 → $66 | Maintains | Hold | Get Alert |
| 10/01/2024 | Buy Now | -9.5% | Evercore ISI Group | Vijay Kumar51% | $76 → $70 | Maintains | In-Line | Get Alert |
| 10/01/2024 | Buy Now | -0.45% | Citigroup | Joanne Wuensch74% | $83 → $77 | Maintains | Buy | Get Alert |
| 09/18/2024 | Buy Now | -9.5% | Jefferies | Matthew Taylor59% | $85 → $70 | Downgrade | Buy → Hold | Get Alert |
| 09/13/2024 | Buy Now | -8.21% | Truist Securities | Richard Newitter74% | $82 → $71 | Maintains | Hold | Get Alert |
| 09/12/2024 | Buy Now | 16.35% | Oppenheimer | Suraj Kalia59% | $90 → $90 | Maintains | Outperform | Get Alert |
| 09/10/2024 | Buy Now | -3.04% | UBS | Danielle Antalffy44% | $90 → $75 | Maintains | Neutral | Get Alert |
| 09/09/2024 | Buy Now | 3.43% | Barclays | Matt Miksic67% | $90 → $80 | Maintains | Overweight | Get Alert |
| 09/09/2024 | Buy Now | 3.43% | Wells Fargo | Larry Biegelsen66% | $90 → $80 | Maintains | Overweight | Get Alert |
| 07/29/2024 | Buy Now | — | Wolfe Research | Mike Polark66% | — | Upgrade | Underperform → Peer Perform | Get Alert |
| 07/26/2024 | Buy Now | 16.35% | Barclays | Matt Miksic67% | $101 → $90 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 17.65% | Goldman Sachs | David Roman40% | $107 → $91 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | -9.5% | TD Cowen | Joshua Jennings56% | $100 → $70 | Downgrade | Buy → Hold | Get Alert |
| 07/25/2024 | Buy Now | 16.35% | Wells Fargo | Larry Biegelsen66% | $99 → $90 | Maintains | Overweight | Get Alert |
| 07/25/2024 | Buy Now | -1.75% | Evercore ISI Group | Vijay Kumar51% | $91 → $76 | Maintains | In-Line | Get Alert |
| 07/25/2024 | Buy Now | 9.89% | Deutsche Bank | Pito Chickering68% | $103 → $85 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 9.89% | RBC Capital | Shagun Singh57% | $101 → $85 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 6.01% | Truist Securities | Richard Newitter74% | $110 → $82 | Downgrade | Buy → Hold | Get Alert |
| 07/25/2024 | Buy Now | -9.5% | Stifel | Rick Wise74% | $85 → $70 | Maintains | Hold | Get Alert |
| 07/25/2024 | Buy Now | 16.35% | Oppenheimer | Suraj Kalia59% | $100 → $90 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | -0.45% | Canaccord Genuity | William Plovanic55% | $85 → $77 | Maintains | Hold | Get Alert |
| 07/25/2024 | Buy Now | -5.62% | Piper Sandler | Adam Maeder63% | $88 → $73 | Maintains | Neutral | Get Alert |
| 07/25/2024 | Buy Now | -3.04% | B of A Securities | Travis Steed58% | $105 → $75 | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2024 | Buy Now | -6.92% | JP Morgan | Robbie Marcus67% | $105 → $72 | Downgrade | Overweight → Neutral | Get Alert |
| 07/25/2024 | Buy Now | -9.5% | Baird | David Rescott65% | $102 → $70 | Downgrade | Outperform → Neutral | Get Alert |
| 07/16/2024 | Buy Now | 42.21% | Truist Securities | Richard Newitter74% | $105 → $110 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 37.04% | Citigroup | Joanne Wuensch74% | $105 → $106 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 17.65% | Evercore ISI Group | Vijay Kumar51% | $89 → $91 | Maintains | In-Line | Get Alert |
| 05/30/2024 | Buy Now | 38.33% | Goldman Sachs | David Roman40% | → $107 | Initiates | → Buy | Get Alert |
| 05/22/2024 | Buy Now | 35.75% | Citigroup | Joanne Wuensch74% | $98 → $105 | Upgrade | Neutral → Buy | Get Alert |
| 05/14/2024 | Buy Now | 33.16% | Deutsche Bank | Pito Chickering68% | $86 → $103 | Upgrade | Hold → Buy | Get Alert |
| 05/07/2024 | Buy Now | 30.58% | Barclays | Matt Miksic67% | $100 → $101 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 9.89% | Canaccord Genuity | William Plovanic55% | $86 → $85 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 27.99% | Wells Fargo | Larry Biegelsen66% | $94 → $99 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 15.06% | Evercore ISI Group | Vijay Kumar51% | $92 → $89 | Maintains | In-Line | Get Alert |
| 04/26/2024 | Buy Now | 9.89% | Stifel | Rick Wise74% | $83 → $85 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 13.77% | Piper Sandler | Adam Maeder63% | $85 → $88 | Maintains | Neutral | Get Alert |
| 04/15/2024 | Buy Now | 30.58% | RBC Capital | Shagun Singh57% | $95 → $101 | Maintains | Outperform | Get Alert |
| 04/11/2024 | Buy Now | 35.75% | Mizuho | Anthony Petrone63% | $95 → $105 | Maintains | Buy | Get Alert |
| 04/04/2024 | Buy Now | 18.94% | Evercore ISI Group | Vijay Kumar51% | $86 → $92 | Maintains | In-Line | Get Alert |
| 04/03/2024 | Buy Now | 26.7% | Citigroup | Joanne Wuensch74% | $90 → $98 | Maintains | Neutral | Get Alert |
| 03/26/2024 | Buy Now | — | OTR Global | — | — | Upgrade | Mixed → Positive | Get Alert |
| 03/21/2024 | Buy Now | 33.16% | Morgan Stanley | Patrick Wood43% | $95 → $103 | Maintains | Overweight | Get Alert |
| 03/18/2024 | Buy Now | 29.28% | Oppenheimer | Suraj Kalia59% | $93 → $100 | Maintains | Outperform | Get Alert |
| 03/07/2024 | Buy Now | — | B of A Securities | Travis Steed58% | — | Upgrade | Neutral → Buy | Get Alert |
| 02/07/2024 | Buy Now | 7.3% | Stifel | Rick Wise74% | $70 → $83 | Maintains | Hold | Get Alert |
| 02/07/2024 | Buy Now | 22.82% | Morgan Stanley | Patrick Wood43% | $80 → $95 | Maintains | Overweight | Get Alert |
| 02/07/2024 | Buy Now | 22.82% | RBC Capital | Shagun Singh57% | $82 → $95 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | 22.82% | Mizuho | Anthony Petrone63% | $85 → $95 | Maintains | Buy | Get Alert |
| 02/02/2024 | Buy Now | 21.53% | Wells Fargo | Larry Biegelsen66% | → $94 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/12/2024 | Buy Now | 6.01% | RBC Capital | Shagun Singh57% | $80 → $82 | Maintains | Outperform | Get Alert |
| 01/04/2024 | Buy Now | -0.45% | Evercore ISI Group | Vijay Kumar51% | $80 → $77 | Downgrade | Outperform → In-Line | Get Alert |
| 12/22/2023 | Buy Now | 8.6% | Truist Securities | Richard Newitter74% | $78 → $84 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | 0.84% | Truist Securities | Richard Newitter74% | $76 → $78 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | — | Citigroup | Joanne Wuensch74% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/04/2023 | Buy Now | 3.43% | Morgan Stanley | Patrick Wood43% | $102 → $80 | Maintains | Overweight | Get Alert |
| 11/28/2023 | Buy Now | -26.31% | Wolfe Research | Mike Polark66% | → $57 | Downgrade | Peer Perform → Underperform | Get Alert |
| 10/26/2023 | Buy Now | -9.5% | Stifel | Rick Wise74% | $87 → $70 | Maintains | Hold | Get Alert |
| 10/26/2023 | Buy Now | 9.89% | Mizuho | Anthony Petrone63% | $90 → $85 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | -1.75% | Truist Securities | Richard Newitter74% | $83 → $76 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | 6.01% | RBC Capital | Shagun Singh57% | $86 → $82 | Maintains | Outperform | Get Alert |
| 10/26/2023 | Buy Now | -12.09% | Piper Sandler | Adam Maeder63% | $83 → $68 | Maintains | Neutral | Get Alert |
| 10/26/2023 | Buy Now | 9.89% | Citigroup | Joanne Wuensch74% | $94 → $85 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | -3.04% | Wells Fargo | Larry Biegelsen66% | $88 → $75 | Maintains | Equal-Weight | Get Alert |
| 10/16/2023 | Buy Now | -3.04% | Leerink Partners | Mike Kratky66% | → $75 | Initiates | → Market Perform | Get Alert |
| 10/02/2023 | Buy Now | 21.53% | Citigroup | Joanne Wuensch74% | $110 → $94 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 16.35% | Oppenheimer | Suraj Kalia59% | → $90 | Upgrade | Perform → Outperform | Get Alert |
| 09/08/2023 | Buy Now | 7.3% | Piper Sandler | Adam Maeder63% | $88 → $83 | Maintains | Neutral | Get Alert |
| 08/17/2023 | Buy Now | 24.11% | RBC Capital | Shagun Singh57% | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | Buy Now | 24.11% | RBC Capital | Shagun Singh57% | → $96 | Reiterates | Outperform → Outperform | Get Alert |
FAQ
What is the target price for Edwards Lifesciences (EW) stock?
The latest price target for Edwards Lifesciences (NYSE:EW) was reported by Citigroup on May 22, 2025. The analyst firm set a price target for $95.00 expecting EW to rise to within 12 months (a possible 22.82% upside). 59 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Edwards Lifesciences (EW)?
The latest analyst rating for Edwards Lifesciences (NYSE:EW) was provided by Citigroup, and Edwards Lifesciences maintained their buy rating.
When was the last upgrade for Edwards Lifesciences (EW)?
The last upgrade for Edwards Lifesciences Corp happened on April 24, 2025 when Piper Sandler raised their price target to $80. Piper Sandler previously had a neutral for Edwards Lifesciences Corp.
When was the last downgrade for Edwards Lifesciences (EW)?
The last downgrade for Edwards Lifesciences Corp happened on January 16, 2025 when Wolfe Research changed their price target from $60 to $60 for Edwards Lifesciences Corp.
When is the next analyst rating going to be posted or updated for Edwards Lifesciences (EW)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Edwards Lifesciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Edwards Lifesciences was filed on May 22, 2025 so you should expect the next rating to be made available sometime around May 22, 2026.
Is the Analyst Rating Edwards Lifesciences (EW) correct?
While ratings are subjective and will change, the latest Edwards Lifesciences (EW) rating was a maintained with a price target of $84.00 to $95.00. The current price Edwards Lifesciences (EW) is trading at is $77.35, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
